HG-146

N/A

Report date: 2024/12/13 20:00:39
NME

Base Information

Drug NameHG-146
Drug Alias NameHG-146
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistone deacetylase inhibitors
TargetsHistone deacetylase
Therapy Area/IndicationsSolid tumoursHead and Neck NeoplasmsMultiple Myeloma +[5
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesHitgen Inc
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesHitgen Inc
Inactive CompaniesN/A
Active IndicationsSolid tumoursHead and Neck NeoplasmsCarcinoma, Adenoid Cystic +[4
Inactive IndicationsMultiple Myeloma

Other Information

ATC CodeN/A
Related LinksN/A